IndiTreat® selected to prestigious multinational ovarian cancer project.
2cureX is pleased to announce that the DECIDER project that aims to develop novel diagnostic tools and effective drug combinations to treat ovarian cancer patients has been awarded a prestigious grant from the EU.2cureX will provide functional precision testing within a prestigious multinational Ovarian Cancer project, DECIDER, which has been granted 15 MEUR from the EU. The invitation to participate is an endorsement of IndiTreat®, and in line with 2cureX’s belief that every cancer patient should be treated individually.
In Europe, over 40.000 women die of ovarian cancer every year. In